Singapore markets closed
Straits Times Index
3,394.21 +17.02 (+0.50%) Nikkei
27,382.56 +19.81 (+0.07%) Hang Seng
22,688.90 +122.12 (+0.54%) FTSE 100
7,765.15 +4.04 (+0.05%) BTC-USD
23,141.53 +38.97 (+0.17%) CMC Crypto 200
526.66 +9.65 (+1.87%)
Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 79.22B |
| Enterprise value | 74.90B |
| Trailing P/E | 15.34 |
| Forward P/E | 18.02 |
| PEG Ratio (5 yr expected) | 9.12 |
| Price/sales (ttm) | 6.01 |
| Price/book (mrq) | 3.70 |
| Enterprise value/revenue | 5.46 |
| Enterprise value/EBITDA | 11.69 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.24 |
| 52-week change 3 | 22.06% |
| S&P500 52-week change 3 | -9.85% |
| 52-week high 3 | 779.00 |
| 52-week low 3 | 538.01 |
| 50-day moving average 3 | 733.21 |
| 200-day moving average 3 | 675.49 |
Share statistics
| Avg vol (3-month) 3 | 636.06k |
| Avg vol (10-day) 3 | 538.62k |
| Shares outstanding 5 | 107.08M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 102.18M |
| % held by insiders 1 | 2.58% |
| % held by institutions 1 | 90.64% |
| Shares short (12 Jan 2023) 4 | 1.41M |
| Short ratio (12 Jan 2023) 4 | 2.21 |
| Short % of float (12 Jan 2023) 4 | 1.37% |
| Short % of shares outstanding (12 Jan 2023) 4 | 1.29% |
| Shares short (prior month 14 Dec 2022) 4 | 1.44M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | 39.17% |
| Operating margin (ttm) | 47.10% |
Management effectiveness
| Return on assets (ttm) | 15.72% |
| Return on equity (ttm) | 27.76% |
Income statement
| Revenue (ttm) | 13.71B |
| Revenue per share (ttm) | 128.16 |
| Quarterly revenue growth (yoy) | -15.00% |
| Gross profit (ttm) | 10.73B |
| EBITDA | 6.77B |
| Net income avi to common (ttm) | 5.37B |
| Diluted EPS (ttm) | 47.44 |
| Quarterly earnings growth (yoy) | -19.40% |
Balance sheet
| Total cash (mrq) | 7.02B |
| Total cash per share (mrq) | 65.75 |
| Total debt (mrq) | 2.7B |
| Total debt/equity (mrq) | 12.60 |
| Current ratio (mrq) | 5.36 |
| Book value per share (mrq) | 200.93 |
Cash flow statement
| Operating cash flow (ttm) | 5.67B |
| Levered free cash flow (ttm) | 2.94B |
© 2023 Yahoo. All rights reserved.
